Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Issue

Free This issue is open to the public.

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Journal of the Neurological Sciences
Volume 206, Issue 2, Pages 123-218 (15 February 2003)
Search Within This Issue
The Progressive Phase of Multiple Sclerosis: Pathology and Treatment. 7th European Charcot foundation Symposium
18 October 2001 - 20 October 2001

display abstract citation download email a colleague
Display:


Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
C Bjartmar, J.R Wujek, B.D Trapp
pages 165-171
Abstract | Full Text | Full-Text PDF (289 KB)


MRI–clinical correlations in the primary progressive course of MS: new insights into the disease pathophysiology from the application of magnetization transfer, diffusion tensor, and functional MRI
Massimo Filippi
pages 157-164
Abstract | Full Text | Full-Text PDF (130 KB)


Remyelination in multiple sclerosis
Wolfgang Brück, Tanja Kuhlmann, Christine Stadelmann
pages 181-185
Abstract | Full Text | Full-Text PDF (182 KB)


Interferon beta 1a for secondary progressive multiple sclerosis
Richard A.C Hughes
pages 199-202
Abstract | Full Text | Full-Text PDF (90 KB)


Mitoxantrone in progressive multiple sclerosis: when and how to treat?
R.E Gonsette
pages 203-208
Abstract | Full Text | Full-Text PDF (110 KB)

7th European Charcot Foundation Lecture


The role of intravenous immunoglobulin in the treatment of multiple sclerosis
Per Soelberg Sorensen
pages 123-130
Abstract | Full Text | Full-Text PDF (120 KB)


The diagnosis of primary progressive multiple sclerosis
Jerry S Wolinsky, the PROMiSe Study Group
pages 145-152
Abstract | Full Text | Full-Text PDF (137 KB)


MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS?
G.R Wayne Moore
pages 175-179
Abstract | Full Text | Full-Text PDF (95 KB)


Clinical–MRI correlations in the secondary progressive phase of MS: lessons from the treatment trials
M Clanet, E Cassol, C Manelfe, I Berry
pages 139-144
Abstract | Full Text | Full-Text PDF (227 KB)


Interferon beta-1a in primary progressive multiple sclerosis
Siobhan M Leary, Alan J Thompson
pages 215-216
Abstract | Full Text | Full-Text PDF (63 KB)


Hypoxia-like tissue injury as a component of multiple sclerosis lesions
Hans Lassmann
pages 187-191
Abstract | Full Text | Full-Text PDF (96 KB)


Primary and secondary progressive multiple sclerosis
Sandra Vukusic, Christian Confavreux
pages 153-155
Abstract | Full Text | Full-Text PDF (76 KB)


Clinical and laboratory characteristics of secondary progressive MS
Jackie Palace
pages 131-134
Abstract | Full Text | Full-Text PDF (189 KB)


Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis
H.F Petereit, R Pukrop, F Fazekas, S.U Bamborschke, S Röpele, H.W Kölmel, S Merkelbach, G Japp, P.J.H Jongen, H.P Hartung, O.R Hommes
pages 209-214
Abstract | Full Text | Full-Text PDF (146 KB)


Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis
Sandra Vukusic, Christian Confavreux
pages 135-137
Abstract | Full Text | Full-Text PDF (92 KB)


Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection
Steve J Jones, Adriana Brusa
pages 193-198
Abstract | Full Text | Full-Text PDF (131 KB)


Differences between subgroups of MS: MRI findings and correlation with histopathology
Geert Lycklama à Nijeholt, Frederik Barkhof
pages 173-174
Full Text | Full-Text PDF (58 KB)


Editorial Board
page CO2
Full-Text PDF (15 KB)


Calendar of Events
pages 217-218
Full-Text PDF (168 KB)

display abstract citation download email a colleague
Display:
Advertisement

Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.